Cell Death: Drug Combo Restores Signaling Ability of Leading Treatment for Blood Cancer Christina Glytsou PhD By Christina Glytsou, PhDAssistant…
Browsing: NYU Langone
SWOG S1801 Trial: Pembro After or Before Surgery? [2022] It is not yet known which type of immunotherapy, adjuvant or…
M14TIL Trial: TIL Compared to Std. Ipilimumab [2022] This is the first experiment to use tumor-infiltrating lymphocytes (TIL) in metastatic…
DASL-HiCaP Phase 3 Trial [2022]: Update David Wise MD Â David Wise, MD Spoke with OncologyTube about the DASL-HiCaP (randomised)…